Study Stopped
Failure to recruit participants due to change in local clinical practice.
Breastfeeding Infants Receiving Respiratory Support Trial
BIRRST
1 other identifier
observational
1
1 country
1
Brief Summary
The purpose of this study is to assess whether two methods of breathing support in babies called 'Humidified High-Flow Nasal Cannula' oxygen (HHFNC) and 'nasal Continuous Positive Airways Pressure' (nCPAP) are compatible with breastfeeding. Many babies who are premature or unwell after birth require help with their breathing. This is often achieved by blowing a continuous flow of air through the nose and down into the lungs in order to reduce the amount of effort the baby needs to inflate the lungs during breathing. Currently some centres allow babies to breastfeed whilst undergoing breathing support whilst other centres do not in case there is an increased risk of choking or other harmful events. In the latter case, babies are fed using a nasogastric tube (NGT) that runs from the baby's nostrils into their stomach. At this centre, babies are allowed to breastfeed whilst simultaneously on either HHFNC or nCPAP. This is because the concerns over the choking risk are not evidence based. This study aims to conclusively prove that thisfeeding protocol is safe and then to expand into other areas of research to find out the following:
- Whether breastfeeding during nCPAP or HHFNC leads to babies establishing full breastfeeding sooner (and subsequently reduce the length of their stay in hospital)
- What the effects of breastfeeding of nCPAP or HHFNC are on a baby's parents (e.g. whether it enhances bonding)
- If nCPAP and HHFNC have different effects on breastfeeding As part of this study the investigators will observe stable babies on nCPAP or HHFNC during breastfeeding episodes. The investigators will monitor the babies for signs of distress or instability and whether they are more stable when breastfeeding is not occurring. This will be compared to an episode where the same baby is fed by NGT to see which technique is better.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2016
CompletedStudy Start
First participant enrolled
November 1, 2016
CompletedFirst Posted
Study publicly available on registry
December 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedApril 11, 2019
April 1, 2019
1 year
November 1, 2016
April 9, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Incidence of episodes of desaturation during a feeding episode
During a feeding episode physiological parameters (heart rate, respiratory rate, oxygen saturation) will be observed continuously using Massimo monitors and recorded every 5 minutes. Any episodes of desaturation will be recorded (duration of time that saturations under 92% and lowest recorded saturations).
30 minutes
Incidence of episodes of bradycardia during a feeding episode
During a feeding episode physiological parameters (heart rate, respiratory rate, oxygen saturation) will be observed continuously using Massimo monitors and recorded every 5 minutes. Any episodes of bradycardia during a feeding episode will be recorded (duration that heart rate is less than 100 beats per minute and lowest recorded heartrate).
30 minutes
Incidence of episodes of apnoea during a feeding episode
During a feeding episode physiological parameters (heart rate, respiratory rate, oxygen saturation) will be observed continuously using a Massimo monitor and recorded every 5 minutes. Any episodes of apnoea during a feeding episode will be recorded (duration of apnoea).
30 minutes
Incidence of episodes of temperature instability during a feeding episode
Temperature will be recorded at beginning and end of a feeding episode (in degrees celsius). Any episodes of temperature instability during a feeding episode will be recorded.
30 minutes
Secondary Outcomes (2)
Breastfeeding behaviours displayed measured using the PIBBS scale
30 minutes
Parental perception of breast feeding an infant receiving respiratory support
One week
Other Outcomes (2)
Gestational age at full oral feeding
Through study completion, an average of six months
Route of oral feeding at discharge
Through study completion, an average of six months
Study Arms (2)
CPAP group
25 infants undergoing treatment with continuous nCPAP who are making attempts at breast feeding and receiving nasogastric feeds.
HHFNC group
25 infants undergoing treatment with continuous HHFNC oxygen who are making attempts at breast feeding and receiving nasogastric feeds.
Interventions
Infants on respiratory support will be allowed to attempt to breast feed (with a top up nasogastric tube feed if required).
The control intervention is feeding via nasogastric tube
Eligibility Criteria
Infants requiring medical care on a neonatal unit who are receiving continuous treatment with nCPAP or HHFNC and are making attempts to breast feed
You may qualify if:
- Infants cared for at Imperial College Healthcare NHS trust neonatal unit at Queen Charlottes and Chelsea Hospital and St Marys Hospital. Infants will be eligible if they are over 30 weeks of gestational age and receive continuous treatment with nCPAP or HHFNC .
You may not qualify if:
- Major congenital malformation or underlying genetic disorder
- signs of severe progressive respiratory distress
- FiO2 \> 0.4
- PCo2 \> 9kPa
- Need for high CPAP \> 8cmH2O
- Need for HHFNC with flow rate of \>8litres/min
- Severe temperature instability, not tolerating 30 min outside the incubator
- CPAP or HHFNC treatment stopped
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Queen Charlotte's and Chelsea Hospital
London, W12 0HS, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexander Rakow, MD
Imperial College NHS Trust
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 2016
First Posted
December 21, 2016
Study Start
November 1, 2016
Primary Completion
November 1, 2017
Study Completion
November 1, 2017
Last Updated
April 11, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will share
Anonymised, non-identifiable data available on request